Amneal 制药 AMRX
$20.14 +$0.69 (+3.55%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $20.14 0.00%
开盘$19.45
昨收$19.45
当日区间$19.30 – $20.43
成交量4.73M
市值$6.43B
市盈率(TTM)50.4
股息率–
股权结构与仓位
谁在持有、谁在做空,以及大资金的流向
机构持股比例48.5%-4.01 个百分点,较上季度
持仓机构数398+18 ,较上季度
内部人近期交易35次买入 / 15次卖出净买入
空头持仓比例4.41% 占流通股回补天数 3.7 · 截至 15 Oct 2026
卖空成交量占比11.8%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入,近20个交易日
大单买入减卖出的净额(美元)。该窗口期内:−$9.74M(7个净流入日,13个净流出日)。
按单量净流入,近20个交易日
超大单/大单近似机构级别交易;中单/小单近似散户级别交易。各档买入减卖出净额,按窗口期累计。
已披露的前五大股东合计持有40.5%的流通股。
最大股东
按投资者类型
过去6次双周报告中(31 Jul 2026至15 Oct 2026),空头持仓占流通股比例已从2.61%升至4.41%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Congress Asset Management Company, LLP | Mutual Fund | 2026/Q3 | +741,577 | 0.4% |
| Tushar Patel | Individual/Insider | 2026/Q3 | +12,763,469 | 17.6% |
| Gautam Patel | Individual/Insider | 2026/Q3 | +283,632 | 0.6% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +389,987 | 0.5% |
| BlackRock | Mutual Fund | 2026/Q3 | +2,042,901 | 7.6% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +812,794 | 3.5% |
| Congress Asset Management Company, LLP | Mutual Fund | 2026/Q3 | +782,778 | 0.2% |
| Allspring Global Investments, LLC | Mutual Fund | 2026/Q3 | +745,961 | 0.9% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +593,401 | 1.5% |
| Pictet Asset Management Limited | Mutual Fund | 2026/Q3 | +582,573 | 0.2% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +562,275 | 2.1% |
| Citadel Advisors LLC | Hedge Fund | 2026/Q3 | +541,296 | 0.3% |
| Goldman Sachs Asset Management, L.P. | Mutual Fund | 2026/Q3 | +522,782 | 0.7% |
| PanAgora Asset Management, Inc. | Mutual Fund | 2026/Q3 | +443,647 | 0.1% |
| Exchange Traded Concepts, LLC | Mutual Fund | 2026/Q3 | +360,106 | 0.1% |
按报告期列出的机构买卖动态,变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 16 Sep 2026 | J. Buchi | Independent Director | Other Disposition | -20,445 | – | 189,021 |
| 10 Sep 2026 | J. Buchi | Independent Director | Derivative Exercise and Retained | +20,445 | $14.45 | 189,021 |
| 31 Aug 2026 | Andrew Boyer | Executive VP and Chief Commercial Officer of Generics & Biosciences | Other Disposition | -80,000 | – | 193,646 |
| 20 Aug 2026 | Andrew Boyer | Executive VP and Chief Commercial Officer of Generics & Biosciences | Other Disposition | -152,426 | – | 273,646 |
| 12 Aug 2026 | John Kiely | Independent Director | Other Disposition | -10,000 | – | 200,252 |
| 12 Aug 2026 | John Kiely | Independent Director | Open Market Disposition | -50,000 | $17.64 | 200,252 |
| 11 Aug 2026 | Nikita Shah | Executive Vice President | Open Market Disposition | -146,403 | $17.51 | 253,390 |
| 11 Aug 2026 | Jason Daly | Executive Vice President | Open Market Disposition | -216,613 | $17.70 | 35,171 |
| 10 Aug 2026 | J. Buchi | Independent Director | Open Market Disposition | -168,573 | $17.18 | 168,576 |
| 9 Aug 2026 | Chirag Patel | Co-Founder, Co-CEO, President & Director | Other Acquisition | +6,381,734 | – | 29,044,624 |
| 9 Aug 2026 | Chintu Patel | Co-Chief Executive Officer | Other Acquisition | +6,381,734 | – | 32,523,507 |
| 9 Aug 2026 | Tushar Patel | Other Acquisition | +12,763,469 | – | 61,341,678 | |
| 9 Aug 2026 | Gautam Patel | Director | Other Acquisition | +283,632 | – | 1,927,595 |
| 10 May 2026 | Deborah Autor | Independent Director | Open Market Disposition | -34,819 | $12.94 | 93,660 |
| 6 May 2026 | Paul Meister | Independent Chairperson | Derivative Exercise and Retained | +48,747 | – | 832,800 |
| 6 May 2026 | J. Buchi | Independent Director | Derivative Exercise and Retained | +34,819 | – | 337,149 |
| 6 May 2026 | Ted Nark | Independent Director | Derivative Exercise and Retained | +34,819 | – | 325,848 |
| 6 May 2026 | Shlomo Yanai | Independent Director | Derivative Exercise and Retained | +34,819 | – | 320,804 |
| 6 May 2026 | Jeffrey George | Independent Director | Derivative Exercise and Retained | +34,819 | – | 344,614 |
| 6 May 2026 | Gautam Patel | Director | Derivative Exercise and Retained | +34,819 | – | 1,643,963 |
数据来自Form 4/Form 144申报文件。负数为减持(出售、赠予或代扣税款股份),正数为增持。
空头持仓(按报告期)
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 14,067,810 | 4.4% | 3.7 |
| 30 Sep 2026 | 11,278,967 | 3.5% | 3.1 |
| 15 Sep 2026 | 11,289,778 | 3.5% | 6.6 |
| 31 Aug 2026 | 10,571,834 | 3.3% | 7.4 |
| 14 Aug 2026 | 9,514,369 | 3.0% | 4.9 |
| 31 Jul 2026 | 8,320,187 | 2.6% | 4.6 |
暂无评论——快来第一个聊聊 AMRX。